CN102503994A - 治疗艰难梭菌相关的腹泻的方法 - Google Patents

治疗艰难梭菌相关的腹泻的方法 Download PDF

Info

Publication number
CN102503994A
CN102503994A CN2011103037682A CN201110303768A CN102503994A CN 102503994 A CN102503994 A CN 102503994A CN 2011103037682 A CN2011103037682 A CN 2011103037682A CN 201110303768 A CN201110303768 A CN 201110303768A CN 102503994 A CN102503994 A CN 102503994A
Authority
CN
China
Prior art keywords
mcc
treatment
days
day
experimenter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011103037682A
Other languages
English (en)
Chinese (zh)
Inventor
帕梅拉·希耶斯
徐润庆
斯达·路易丝·米勒-香格勒
罗伯特·布雷恩·沃尔士
法拉·巴巴汉
崔宇亨
亚历克斯·罗梅罗
舍伍德·戈尔巴奇
托马斯·约翰·路易
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Optimer Pharmaceuticals LLC
Original Assignee
Optimer Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Optimer Pharmaceuticals LLC filed Critical Optimer Pharmaceuticals LLC
Publication of CN102503994A publication Critical patent/CN102503994A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN2011103037682A 2005-10-21 2006-10-23 治疗艰难梭菌相关的腹泻的方法 Pending CN102503994A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US72913505P 2005-10-21 2005-10-21
US60/729,135 2005-10-21
US74964105P 2005-12-12 2005-12-12
US60/749,641 2005-12-12

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN2006800479861A Division CN101340919B (zh) 2005-10-21 2006-10-23 治疗艰难梭菌相关的腹泻的方法

Publications (1)

Publication Number Publication Date
CN102503994A true CN102503994A (zh) 2012-06-20

Family

ID=37963388

Family Applications (2)

Application Number Title Priority Date Filing Date
CN2011103037682A Pending CN102503994A (zh) 2005-10-21 2006-10-23 治疗艰难梭菌相关的腹泻的方法
CN2006800479861A Expired - Fee Related CN101340919B (zh) 2005-10-21 2006-10-23 治疗艰难梭菌相关的腹泻的方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN2006800479861A Expired - Fee Related CN101340919B (zh) 2005-10-21 2006-10-23 治疗艰难梭菌相关的腹泻的方法

Country Status (7)

Country Link
EP (1) EP1940417A4 (https=)
JP (1) JP2009512691A (https=)
KR (1) KR101399621B1 (https=)
CN (2) CN102503994A (https=)
AU (1) AU2006304868B2 (https=)
CA (1) CA2626698C (https=)
WO (1) WO2007048059A2 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104846044A (zh) * 2014-02-17 2015-08-19 上海医药工业研究院 一种提高非达霉素产量的发酵培养基
CN105237599A (zh) * 2015-10-09 2016-01-13 华北制药集团新药研究开发有限责任公司 闰年霉素a4晶体及其制备方法

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7906489B2 (en) 2004-05-14 2011-03-15 Optimer Pharmaceuticals, Inc. 18-membered macrocycles and analogs thereof
US7378508B2 (en) 2007-01-22 2008-05-27 Optimer Pharmaceuticals, Inc. Polymorphic crystalline forms of tiacumicin B
TWI523654B (zh) 2007-11-27 2016-03-01 默沙東藥廠 抗生素巨環化合物以及其製造及使用之方法
JO3464B1 (ar) 2013-01-15 2020-07-05 Astellas Pharma Europe Ltd التركيبات الخاصة بمركبات التياكوميسين
CN107970253B (zh) * 2017-10-25 2020-05-26 中山大学 台勾霉素衍生物在制备治疗寨卡病毒感染引起的相关疾病和/或症状的药物中的应用
CN107714713B (zh) * 2017-10-25 2020-05-26 中山大学 台勾霉素衍生物在制备治疗登革病毒感染引起的相关疾病和/或症状的药物中的应用
CN112805367B (zh) * 2018-06-07 2024-08-09 阿尔图根治疗有限公司 用于治疗艰难梭菌的方法和组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4918174A (en) 1986-09-26 1990-04-17 Abbott Laboratories Tiacumicin compounds
US5583115A (en) * 1995-05-09 1996-12-10 Abbott Laboratories Dialkyltiacumicin compounds
WO2004014295A2 (en) * 2002-07-29 2004-02-19 Optimer Pharmaceuticals, Inc. Tiacumicin production
HUE031581T2 (en) * 2004-05-14 2017-07-28 Merck Sharp & Dohme Treatment of diseases associated with the use of antibiotics
CN102614207B (zh) * 2005-01-31 2016-01-13 默克夏普&多梅有限公司 18元环大环化合物及其类似物

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104846044A (zh) * 2014-02-17 2015-08-19 上海医药工业研究院 一种提高非达霉素产量的发酵培养基
CN104846044B (zh) * 2014-02-17 2019-02-01 上海医药工业研究院 一种提高非达霉素产量的发酵培养基
CN105237599A (zh) * 2015-10-09 2016-01-13 华北制药集团新药研究开发有限责任公司 闰年霉素a4晶体及其制备方法
CN105237599B (zh) * 2015-10-09 2018-10-02 华北制药集团新药研究开发有限责任公司 闰年霉素a4晶体及其制备方法

Also Published As

Publication number Publication date
AU2006304868B2 (en) 2013-02-21
CA2626698C (en) 2015-12-01
CN101340919B (zh) 2011-12-07
KR20080064177A (ko) 2008-07-08
AU2006304868A1 (en) 2007-04-26
EP1940417A2 (en) 2008-07-09
JP2009512691A (ja) 2009-03-26
CA2626698A1 (en) 2007-04-26
HK1126410A1 (en) 2009-09-04
WO2007048059A3 (en) 2007-05-31
KR101399621B1 (ko) 2014-06-18
WO2007048059A2 (en) 2007-04-26
CN101340919A (zh) 2009-01-07
EP1940417A4 (en) 2010-07-07

Similar Documents

Publication Publication Date Title
George et al. In vitro and in silico docking studies of antibacterial compounds derived from endophytic Penicillium setosum
Martins et al. Plants used in folk medicine: The potential of their hydromethanolic extracts against Candida species
US20140107054A1 (en) Method of treating clostridium difficile-associated diarrhea
Cheesman et al. An assessment of the growth inhibition profiles of Hamamelis virginiana L. extracts against Streptococcus and Staphylococcus spp.
Wang et al. Polyketide glycosides from Bionectria ochroleuca inhibit Candida albicans biofilm formation
CN101340919B (zh) 治疗艰难梭菌相关的腹泻的方法
Paul et al. Biochemical and in silico study of leaf and bark extracts from Aphanamixis polystachya against common pathogenic bacteria
Xie et al. A new calcium (II) complex of marbofloxacin showing much lower acute toxicity with retained antibacterial activity
Potapenko et al. Antimicrobial and anticancer activity of Streptomyces ambofaciens (Myt 8) and S. globisporus ONU 1019 (Myt 11) secondary metabolites isolated from the Odesa Bay, the Black Sea: an in vitro study
Devnath et al. HPLC Analysis and Antimicrobial, Antidiarrheal and Antihyperglycemic Properties of Eurya acuminata along with in silico Profiles
Agrawal et al. Antioxidant and antibacterial evaluation of leaf extracts of Prunus cerasoides Buch.-Ham. ex D. Don; An In Vitro and In Silico study
Allami et al. Antimicrobial activity of herbal mixture extract combination on microorganisms isolated from urinary tract infection
Handayani et al. Holothurin compound from sea cucumber (Holothuria sp.) as antifungal alternative against Candida infections
Ligacheva et al. Study of Immunotropic Properties of Water-Soluble Polysaccharides Isolated from Conium maculatum Grass.
Isleem et al. Deciphering the nature and statistical optimization of antimicrobial metabolites of two endophytic bacilli
Zai et al. Antimicrobial activity of selected native Australian Terminalia spp. against gastrointestinal pathogens and potentiation of selected antibiotics
Zhi et al. Siderophore-mediated zinc acquisition enhances enterobacterial colonization of the inflamed gut
Khadagwanshi et al. Effect of Phaseolus vulgaris on E. coli induced peritonitis and bacteraemia in mice.
Tanaja et al. Antibacterial activity of ethanolic extract of kitolod (Hippobroma longiflora) leaves against Streptococcus pyogenes
Nchabeleng Determination of biological activity of Celtis africana extracts and its endophytic microflora and mycoflora
CN104248637A (zh) 白鲜碱在制备抗白色念珠菌药物中的应用
Jaber Metabolomic profiling of antibiofilm compounds from fungal endophytes derived from Scottish seaweeds
Sarkiyayi et al. Studies on anti typhoid properties of aqueous methanol leaves extract of Albizia ferruginea (musase)
Alqahtani Antibacterial Compounds from Bacteria Isolated from Hot Springs Water in Saudi Arabia
MUNANIE ANTIBACTERIAL EFFICACY OF ETHANOLIC EXTRACTS FROM RHIZOME BARK AND TUBER OF Colocasia esculenta (L) Schott, Cranberry variety (ARROWROOT), PHYTOCHEMICAL ANALYSIS AND MINIMUM INHIBITORY CONCENTRATION DETERMINATION AGAINST Salmonella typhi, Klebsiella pneumoniae and Acinetobacter baumanii

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent of invention or patent application
CB02 Change of applicant information

Address after: California, USA

Applicant after: Optimer Pharmaceuticals Inc.

Address before: California, USA

Applicant before: Optimer Pharmaceuticals, Inc.

COR Change of bibliographic data

Free format text: CORRECT: APPLICANT; FROM: OPTIMER PHARMACEUTICALS INC. TO: HAODING BIOTECHCX INC.

C53 Correction of patent of invention or patent application
CB02 Change of applicant information

Address after: No. 65 Hayden Avenue, Lexington, Massachusetts, United States

Applicant after: Optimer Pharmaceuticals Inc.

Address before: California, USA

Applicant before: Optimer Pharmaceuticals Inc.

C41 Transfer of patent application or patent right or utility model
CB02 Change of applicant information

Address after: No. 65 Hayden Avenue, Lexington, Massachusetts, United States

Applicant after: Hao Ding biotech Co.,Ltd.

Address before: No. 65 Hayden Avenue, Lexington, Massachusetts, United States

Applicant before: Optimer Pharmaceuticals Inc.

COR Change of bibliographic data
TA01 Transfer of patent application right

Effective date of registration: 20151218

Address after: New jersey, USA

Applicant after: Optimer Biotechnology Inc.

Address before: No. 65 Hayden Avenue, Lexington, Massachusetts, United States

Applicant before: Hao Ding biotech Co.,Ltd.

C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20120620